PUZZLEPHARM Trademark

Trademark Overview

On Monday, January 22, 2024, a trademark application was filed for PUZZLEPHARM with the United States Patent and Trademark Office. The USPTO has given the PUZZLEPHARM trademark a serial number of 98369635. The federal status of this trademark filing is ABANDONED - EXPRESS as of Saturday, May 31, 2025. This trademark is owned by ND Enterprise, LLC. The PUZZLEPHARM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
puzzlepharm

General Information

Serial Number98369635
Word MarkPUZZLEPHARM
Filing DateMonday, January 22, 2024
Status601 - ABANDONED - EXPRESS
Status DateSaturday, May 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkPUZZLE PHARM
Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code042
First Use Anywhere DateTuesday, April 25, 2023
First Use In Commerce DateFriday, September 1, 2023

Trademark Owner History

Party NameND Enterprise, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Milford, CT 06776

Trademark Events

Event DateEvent Description
Monday, January 22, 2024NEW APPLICATION ENTERED
Wednesday, May 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 24, 2024LETTER OF SUSPENSION E-MAILED
Sunday, August 18, 2024ASSIGNED TO EXAMINER
Saturday, August 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, August 24, 2024SUSPENSION LETTER WRITTEN
Friday, November 22, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2024ASSIGNED TO LIE
Monday, December 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2025NON-FINAL ACTION WRITTEN
Tuesday, January 21, 2025NON-FINAL ACTION E-MAILED
Sunday, April 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, April 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 22, 2025FINAL REFUSAL E-MAILED
Thursday, May 22, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 22, 2025FINAL REFUSAL WRITTEN
Friday, May 30, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, May 31, 2025ABANDONMENT - EXPRESS MAILED
Saturday, May 31, 2025ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

Related Keywords

puzzlepharm development products pharmaceutical